advertisement
Kinoshita S 23
Showing records 1 to 23 | Display all abstracts from Kinoshita S86852 Risk Factors for Corneal Endothelial Cell Loss in Patients with Pseudoexfoliation Syndrome
Aoki T
Scientific reports 2020; 10: 7260
86655 Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation
Maruyama Y
British Journal of Ophthalmology 2021; 105: 169-173
86452 Safety and Efficacy of Long-Term Ripasudil 0.4% Instillation for the Reduction of Intraocular Pressure in Japanese Open-Angle Glaucoma Patients
Maruyama Y
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 229-233
86852 Risk Factors for Corneal Endothelial Cell Loss in Patients with Pseudoexfoliation Syndrome
Kitazawa K
Scientific reports 2020; 10: 7260
86655 Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation
Ikeda Y
British Journal of Ophthalmology 2021; 105: 169-173
86452 Safety and Efficacy of Long-Term Ripasudil 0.4% Instillation for the Reduction of Intraocular Pressure in Japanese Open-Angle Glaucoma Patients
Ikeda Y
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 229-233
86655 Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation
Mori K
British Journal of Ophthalmology 2021; 105: 169-173
86452 Safety and Efficacy of Long-Term Ripasudil 0.4% Instillation for the Reduction of Intraocular Pressure in Japanese Open-Angle Glaucoma Patients
Mori K
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 229-233
86852 Risk Factors for Corneal Endothelial Cell Loss in Patients with Pseudoexfoliation Syndrome
Inatomi T
Scientific reports 2020; 10: 7260
86655 Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation
Yoshii K
British Journal of Ophthalmology 2021; 105: 169-173
86452 Safety and Efficacy of Long-Term Ripasudil 0.4% Instillation for the Reduction of Intraocular Pressure in Japanese Open-Angle Glaucoma Patients
Yoshii K
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 229-233
86852 Risk Factors for Corneal Endothelial Cell Loss in Patients with Pseudoexfoliation Syndrome
Kusada N
Scientific reports 2020; 10: 7260
86655 Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation
Ueno M
British Journal of Ophthalmology 2021; 105: 169-173
86852 Risk Factors for Corneal Endothelial Cell Loss in Patients with Pseudoexfoliation Syndrome
Horiuchi N
Scientific reports 2020; 10: 7260
86452 Safety and Efficacy of Long-Term Ripasudil 0.4% Instillation for the Reduction of Intraocular Pressure in Japanese Open-Angle Glaucoma Patients
Ueno M
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 229-233
86655 Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation
Yoshikawa H
British Journal of Ophthalmology 2021; 105: 169-173
86852 Risk Factors for Corneal Endothelial Cell Loss in Patients with Pseudoexfoliation Syndrome
Takeda K
Scientific reports 2020; 10: 7260
86452 Safety and Efficacy of Long-Term Ripasudil 0.4% Instillation for the Reduction of Intraocular Pressure in Japanese Open-Angle Glaucoma Patients
Sotozono C
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 229-233
86655 Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation
Sotozono C
British Journal of Ophthalmology 2021; 105: 169-173
86852 Risk Factors for Corneal Endothelial Cell Loss in Patients with Pseudoexfoliation Syndrome
Yokoi N
Scientific reports 2020; 10: 7260
86452 Safety and Efficacy of Long-Term Ripasudil 0.4% Instillation for the Reduction of Intraocular Pressure in Japanese Open-Angle Glaucoma Patients
Kinoshita S
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 229-233
86655 Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation
Kinoshita S
British Journal of Ophthalmology 2021; 105: 169-173
86852 Risk Factors for Corneal Endothelial Cell Loss in Patients with Pseudoexfoliation Syndrome
Kinoshita S; Sotozono C
Scientific reports 2020; 10: 7260
